UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

Intervirology, 2005-01, Vol.48 (6), p.372-380

2005

Volltextzugriff (PDF)

Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa

Antiviral research, 2016-03, Vol.127, p.90-98

2016

Volltextzugriff (PDF)

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

The Journal of infectious diseases, 2019-03, Vol.219 (7), p.1026-1034

2019

Volltextzugriff (PDF)

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

PloS one, 2010-02, Vol.5 (2), p.e9032

2010

Volltextzugriff (PDF)

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy

Liver international, 2011-10, Vol.31 (9), p.1359-1365

2011

Volltextzugriff (PDF)

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Gastroenterology (New York, N.Y. 1943), 2018-03, Vol.154 (4), p.976-988.e4

2018

Volltextzugriff (PDF)

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

Journal of viral hepatitis, 2011-04, Vol.18 (4), p.280-286

2011

Volltextzugriff (PDF)

Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

Journal of medical virology, 2009-04, Vol.81 (4), p.640

2009

Volltextzugriff (PDF)

NS5A inhibitors in the treatment of hepatitis C

Journal of hepatology, 2013-08, Vol.59 (2), p.375-382

Pawlotsky, Jean-Michel

2013

Volltextzugriff (PDF)

Entecavir resistance mutations rtL180M/T184L/M204V combined with rtA200V lead to tenofovir resistance

Liver international, 2020-01, Vol.40 (1), p.83-91

2020

Volltextzugriff (PDF)

Mutations in different regions of the genome of hepatitis C virus genotype 1b and association with response to interferon therapy

International journal of molecular medicine, 2012-12, Vol.30 (6), p.1438-1442

2012

Volltextzugriff (PDF)

Resistance analysis in patients with genotype 1–6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies

Journal of hepatology, 2018-05, Vol.68 (5), p.895-903

2018

Volltextzugriff (PDF)

Hepatitis C virus-related resistance mechanisms to interferon α-based antiviral therapy

Journal of clinical virology, 2005-02, Vol.32 (2), p.86-91

2005

Volltextzugriff (PDF)

Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy

Antiviral therapy, 2010-01, Vol.15 (8), p.1087-1097

2010

Volltextzugriff (PDF)

Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir

Gastroenterology (New York, N.Y. 1943), 2019-09, Vol.157 (3), p.692-704.e9

2019

Volltextzugriff (PDF)

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

Gastroenterology (New York, N.Y. 1943), 2004-01, Vol.126 (1), p.81-90

2004

Volltextzugriff (PDF)

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

Journal of hepatology, 2013-04, Vol.58 (4), p.646-654

2013

Volltextzugriff (PDF)

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies

Clinical infectious diseases, 2017-01, Vol.64 (1), p.44-52

2017

Volltextzugriff (PDF)

Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir

Hepatology (Baltimore, Md.), 2013-09, Vol.58 (3), p.902-911

2013

Volltextzugriff (PDF)

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy

Journal of medical virology, 2004-09, Vol.74 (1), p.41-53

2004

Volltextzugriff (PDF)

Contribution of insertions and deletions to the variability of hepatitis C virus populations

Journal of general virology, 2007-08, Vol.88 (8), p.2198-2203

2007

Volltextzugriff (PDF)

Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs

International journal of biological macromolecules, 2021-01, Vol.168, p.272-278

2021

Volltextzugriff (PDF)

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

Gastroenterology (New York, N.Y. 1943), 2019-12, Vol.157 (6), p.1506-1517.e1

2019

Volltextzugriff (PDF)

Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis

Gastroenterology (New York, N.Y. 1943), 2017-05, Vol.152 (6), p.1372-1382.e2

2017

Volltextzugriff (PDF)

Multiple effects of honokiol on the life cycle of hepatitis C virus

Liver international, 2012-07, Vol.32 (6), p.989-997

2012

Volltextzugriff (PDF)

1 – 25 von 1.641

Suche als RSS-Feed

Aktive Filter

ThemaDrug Therapy, Combination

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.511)
Mit Volltextzugriff
(1.340)

Publikationsform

Artikel
(1.641)

Sprache

12 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(1.628)
Science & Technology
(1.402)
Life Sciences & Biomedicine
(1.370)
Hepacivirus - Genetics
(1.235)
Antiviral Agents - Therapeutic Use
(1.192)
Male
(1.178)
Female
(1.137)
Hepatitis C, Chronic - Drug Therapy
(1.070)
Interferon-Alpha - Therapeutic Use
(1.046)
Middle Aged
(1.018)
Ribavirin - Therapeutic Use
(1.010)
Adult
(948)
Treatment Outcome
(938)
Genotype
(891)
Gastroenterology & Hepatology
(790)
Polyethylene Glycols - Therapeutic Use
(759)
Recombinant Proteins
(727)
Infectious Diseases
(616)
Hepatitis C, Chronic - Virology
(581)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Association of Amino Acid Substitution Pattern in Core Protein of Hepatitis C Virus Genotype 1b High Viral Load and Non-Virological Response to Interferon-Ribavirin Combination Therapy

Naturally occurring resistance mutations within the core and NS5B regions in hepatitis C genotypes, particularly genotype 5a, in South Africa

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

Contribution of genome-wide HCV genetic differences to outcome of interferon-based therapy in Caucasian American and African American patients

Association of interleukin 28B and mutations in the core and NS5A region of hepatitis C virus with response to peg-interferon and ribavirin therapy

Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting Antivirals

Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy

Randomized trial of high-dose interferon-alpha-2b combined with ribavirin in patients with chronic hepatitis C: Correlation between amino acid substitutions in the core/NS5A region and virological response to interferon therapy

NS5A inhibitors in the treatment of hepatitis C

Entecavir resistance mutations rtL180M/T184L/M204V combined with rtA200V lead to tenofovir resistance

Mutations in different regions of the genome of hepatitis C virus genotype 1b and association with response to interferon therapy

Resistance analysis in patients with genotype 1–6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies

Hepatitis C virus-related resistance mechanisms to interferon α-based antiviral therapy

Amino acid substitutions in core and NS5A regions of the HCV genome can predict virological decrease with pegylated interferon plus ribavirin therapy

Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to Sofosbuvir

Adefovir dipivoxil added to ongoing lamivudine in chronic hepatitis B with YMDD mutant hepatitis B virus

Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir

Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies

Resistance analysis of hepatitis C virus genotype 1 prior treatment null responders receiving daclatasvir and asunaprevir

Genetic variability of hepatitis C virus in chronically infected patients with viral breakthrough during interferon-ribavirin therapy

Contribution of insertions and deletions to the variability of hepatitis C virus populations

Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

Safety and Efficacy of Elbasvir/Grazoprevir in Patients With Hepatitis C Virus Infection and Compensated Cirrhosis: An Integrated Analysis

Multiple effects of honokiol on the life cycle of hepatitis C virus

Aktive Filter

Suchergebnisse filtern